首頁 境外基金 境外基金-持股
目前無資料
基金投資分佈(依產業)
資料日期:2024/08/30


產業投資金額(美元 :以萬元為單位)比例(%)
生物科技 636,499.60 81.09
生命科學服務 126,059.70 16.06
藥品 18,367.40 2.34
醫療保健設備 1,412.90 0.18
醫療服務 1,255.90 0.16
現金及/或衍生產品 1,098.90 0.14
特殊化學用品 157.00 0.02
iShares那斯達克生技指數IBB.US-投資明細
資料月份:2024/07
投資名稱比例 
GILEAD SCIENCES INC 8.57%
REGENERON PHARMACEUTICALS INC 7.98%
VERTEX PHARMACEUTICALS INC 7.89%
AMGEN INC 7.87%
IQVIA HOLDINGS INC 4.07%
MODERNA INC 3.75%
METTLER TOLEDO INC 2.99%
BIOGEN INC 2.88%
ALNYLAM PHARMACEUTICALS INC 2.79%
ARGENX SE ADR 2.43%
WATERS CORP 1.86%
ILLUMINA INC 1.82%
BIONTECH SE ADR 1.64%
GENMABSPONSORED ADR 1.50%
BIOMARIN PHARMACEUTICAL INC 1.47%
INCYTE CORP 1.34%
NEUROCRINE BIOSCIENCES INC 1.30%
BEIGENE ADS REPRESENTING LTD 1.26%
UNITED THERAPEUTICS CORP 1.21%
BIO TECHNE CORP 1.19%
SAREPTA THERAPEUTICS INC 1.18%
CHARLES RIVER LABORATORIES INTERNA 1.16%
NATERA INC 1.10%
INSMED INC 0.98%
MEDPACE HOLDINGS INC 0.91%
LEGEND BIOTECHADR REP CORP 0.81%
REPLIGEN CORP 0.81%
VAXCYTE INC 0.76%
INTRA CELLULAR THERAPIES INC 0.73%
HALOZYME THERAPEUTICS INC 0.65%
BRUKER CORP 0.62%
EXELIXIS INC 0.62%
BLUEPRINT MEDICINES CORP 0.62%
IONIS PHARMACEUTICALS INC 0.62%
ASCENDIS PHARMA ADR REPRESENTING 0.61%
CYTOKINETICS INC 0.59%
REVOLUTION MEDICINES INC 0.59%
ROIVANT SCIENCES LTD 0.52%
KRYSTAL BIOTECH INC 0.47%
MADRIGAL PHARMACEUTICALS INC 0.46%
CRISPR THERAPEUTICS AG 0.43%
ALKERMES 0.43%
APELLIS PHARMACEUTICALS INC 0.37%
CRINETICS PHARMACEUTICALS INC 0.37%
AVIDITY BIOSCIENCES INC 0.36%
BRIDGEBIO PHARMA INC 0.34%
ULTRAGENYX PHARMACEUTICAL INC 0.33%
AXSOME THERAPEUTICS INC 0.32%
ARROWHEAD PHARMACEUTICALS INC 0.31%
IDEAYA BIOSCIENCES INC 0.30%
XENON PHARMACEUTICALS INC 0.30%
ACADIA PHARMACEUTICALS INC 0.29%
TWIST BIOSCIENCE CORP 0.29%
BIOHAVEN LTD 0.28%
AMICUS THERAPEUTICS INC 0.28%
DENALI THERAPEUTICS INC 0.27%
ADMA BIOLOGICS INC 0.26%
DYNE THERAPEUTICS INC 0.26%
NUVALENT INC CLASS A 0.25%
RHYTHM PHARMACEUTICALS INC 0.25%
MERUS NV 0.24%
AGIOS PHARMACEUTICALS INC 0.24%
KYMERA THERAPEUTICS INC 0.24%
PTC THERAPEUTICS INC 0.23%
INTELLIA THERAPEUTICS INC 0.23%
ARCELLX INC 0.23%
VERICEL CORP 0.23%
BEAM THERAPEUTICS INC 0.23%
MYRIAD GENETICS INC 0.23%
MORPHOSYSADR REPRESENTING AG 0.22%
FORTREA HOLDINGS INC 0.22%
GERON CORP 0.22%
SPRINGWORKS THERAPEUTICS INC 0.22%
MORPHIC HOLDING INC 0.21%
NOVOCURE LTD 0.21%
BLK CSH FND TREASURY SL AGENCY 0.19%
PROTAGONIST THERAPEUTICS INC 0.19%
10X GENOMICS INC CLASS A 0.19%
ROCKET PHARMACEUTICALS INC 0.19%
IOVANCE BIOTHERAPEUTICS INC 0.18%
LIGAND PHARMACEUTICALS INC 0.18%
APOGEE THERAPEUTICS INC 0.18%
VERACYTE INC 0.17%
SYNDAX PHARMACEUTICALS INC 0.17%
IMMUNOVANT INC 0.17%
NOVAVAX INC 0.16%
STRUCTURE THERAPEUTICS ADR INC 0.16%
GRIFOLS ADR REPRESENTING ONE NON-V 0.16%
ARVINAS INC 0.15%
RECURSION PHARMACEUTICALS INC CLAS 0.15%
ZAI LABORATORY ADR REPRESENTING LT 0.15%
IMMUNOCORE HOLDINGS ADR PLC 0.15%
AKERO THERAPEUTICS INC 0.15%
MIRUM PHARMACEUTICALS INC 0.14%
VERA THERAPEUTICS INC CLASS A 0.14%
MANNKIND CORP 0.14%
GALAPAGOS ADR REPRESENTING NV 0.14%
DYNAVAX TECHNOLOGIES CORP 0.14%
BIOCRYST PHARMACEUTICALS INC 0.13%
JANUX THERAPEUTICS INC 0.13%
KURA ONCOLOGY INC 0.13%
KEROS THERAPEUTICS INC 0.13%
NURIX THERAPEUTICS INC 0.12%
XENCOR INC 0.11%
VERONA PHARMA ADR PLC 0.11%
EDGEWISE THERAPEUTICS INC 0.10%
PROTHENA PLC 0.10%
MARAVAI LIFESCIENCES HOLDINGS INC 0.10%
IRONWOOD PHARMA INC CLASS A 0.10%
KINIKSA PHARMACEUTICALS INTERNATIO 0.10%
STEVANATO GROUP 0.10%
USD CASH 0.09%
AUTOLUS THERAPEUTICS ADR PLC 0.09%
RELAY THERAPEUTICS INC 0.09%
CAREDX INC 0.09%
ARCUTIS BIOTHERAPEUTICS INC 0.08%
VIR BIOTECHNOLOGY INC 0.08%
SUMMIT THERAPEUTICS INC 0.08%
BICYCLE THERAPEUTICS ADR PLC 0.08%
DAY ONE BIOPHARMACEUTICALS INC 0.08%
HUMACYTE INC 0.08%
ANAPTYSBIO INC 0.08%
89BIO INC 0.08%
CULLINAN THERAPEUTICS INC 0.08%
CYTEK BIOSCIENCES INC 0.07%
ARCUS BIOSCIENCES INC 0.07%
OLEMA PHARMACEUTICALS INC 0.07%
4D MOLECULAR THERAPEUTICS INC 0.07%
PLIANT THERAPEUTICS INC 0.07%
AURINIA PHARMACEUTICALS INC 0.07%
TARSUS PHARMACEUTICALS INC 0.07%
SANA BIOTECHNOLOGY INC 0.07%
DISC MEDICINE INC 0.07%
TRAVERE THERAPEUTICS INC 0.07%
COGENT BIOSCIENCES INC 0.07%
ENLIVEN THERAPEUTICS INC 0.07%
ZYMEWORKS INC 0.06%
ABCELLERA BIOLOGICS INC 0.06%
ADAPTIVE BIOTECHNOLOGIES CORP 0.06%
REGENXBIO INC 0.06%
WAVE LIFE SCIENCES LTD 0.06%
CENTESSA PHARMACEUTICALS AMERICAN 0.06%
CASTLE BIOSCIENCES INC 0.06%
NUVATION BIO INC CLASS A 0.06%
SCHOLAR ROCK HOLDING CORP 0.05%
ARCTURUS THERAPEUTICS HOLDINGS INC 0.05%
ANAVEX LIFE SCIENCES CORP 0.05%
UROGEN PHARMA LTD 0.05%
ARBUTUS BIOPHARMA CORP 0.05%
PACIFIC BIOSCIENCES OF CALIFORNIA 0.05%
SAGE THERAPEUTICS INC 0.05%
EXSCIENTIA ADR PLC 0.05%
FULCRUM THERAPEUTICS INC 0.05%
GINKGO BIOWORKS HOLDINGS INC CLASS 0.05%
TANGO THERAPEUTICS INC 0.05%
ERASCA INC 0.05%
QUANTERIX CORP 0.05%
REPLIMUNE GROUP INC 0.05%
ITEOS THERAPEUTICS INC 0.05%
ORIC PHARMACEUTICALS INC 0.05%
Y MABS THERAPEUTICS INC 0.04%
FULGENT GENETICS INC 0.04%
OPKO HEALTH INC 0.04%
ARS PHARMACEUTICALS INC 0.04%
ALECTOR INC 0.04%
THERAVANCE BIOPHARMA INC 0.04%
MAXCYTE INC 0.04%
EDITAS MEDICINE INC 0.04%
VERVE THERAPEUTICS INC 0.04%
VOYAGER THERAPEUTICS INC 0.04%
COMPASS PATHWAYS ADR PLC 0.04%
KALVISTA PHARMACEUTICALS INC 0.04%
SAVARA INC 0.04%
ACELYRIN INC 0.04%
UNIQURE NV 0.03%
ALLOGENE THERAPEUTICS INC 0.03%
REVANCE THERAPEUTICS INC 0.03%
CUREVAC NV 0.03%
TERNS PHARMACEUTICALS INC 0.03%
PHATHOM PHARMACEUTICALS INC 0.03%
VANDA PHARMACEUTICALS INC 0.03%
TAYSHA GENE THERAPIES INC 0.03%
CABALETTA BIO INC 0.03%
PRIME MEDICINE INC 0.03%
ATEA PHARMACEUTICALS INC 0.03%
TOURMALINE BIO INC 0.02%
IMMUTEP ADS REPRESENTINGLTD 0.02%
MINERALYS THERAPEUTICS INC 0.02%
MEIRAGTX HOLDINGS PLC 0.02%
ZENTALIS PHARMACEUTICALS INC 0.02%
AC IMMUNE SA 0.02%
BLUEBIRD BIO INC 0.02%
MACROGENICS INC 0.02%
NAUTILUS BIOTECHNOLGY INC 0.02%
PRECIGEN INC 0.02%
LYELL IMMUNOPHARMA INC 0.02%
CARIBOU BIOSCIENCES INC 0.02%
CASH COLLATERAL USD SGAFT 0.02%
THIRD HARMONIC BIO INC 0.02%
ATAI LIFE SCIENCES N V NV 0.02%
NANOBIOTIX ADR REPRESENTING SA 0.02%
COHERUS BIOSCIENCES INC 0.02%
BIOMEA FUSION INC 0.02%
ALX ONCOLOGY HOLDINGS INC 0.01%
VENTYX BIOSCIENCES INC 0.01%

附註:
一、 績效計算為原幣別報酬,且皆有考慮配息情況。基金配息率不代表基金報酬率,且過去配息率不代表未來配息率。所有基金績效,均為過去績效,不代表未來之績效表現,亦不保證基金之最低投資收益。所有基金風險值僅供參考,實際以基金公司公告為準。
二、 基金淨值可能因市場因素而上下波動,基金淨值僅供參考,實際以基金公司公告之淨值為準;海外市場指數類型基金,以交易日當天收盤價為淨值參考價。
三、 有關基金應負擔之費用(含分銷費用)已揭露於基金之公開說明書及投資人須知中,投資人可至境外基金資訊觀測站(http://www.fundclear.com.tw)下載,或逕向總代理人網站查閱。
四、 上述銷售費用僅供參考,實際費率以各銷售機構為主。
五、 上述短線交易規定資料僅供參考,實際規定應以基金公開說明書為主。
六、 標示"(已撤銷核備)"及"(未申報生效)"之基金資料僅提供原有投資者參考,以供其做買回、轉換或繼續持有之決定;「已撤銷核備」為在台灣已下架(停售)的基金;「未申報生效」為未於法規規定之時效內向金管會辦理申報生效作業之境外基金。
七、 境外基金經行政院金融監督管理委員會核准或申報生效在國內募集及銷售,惟不表示絕無風險。基金經理公司以往之經理績效不保證基金之最低投資收益;基金經理公司除盡善良管理人之注意義務外,不負責本基金之盈虧,亦不保證最低之收益,投資人申購前應詳閱基金公開說明書。
八、 依金管會規定基金投資大陸證券市場之有價證券不得超過本基金資產淨值之10%,當該基金投資地區包含中國大陸及香港,基金淨值可能因為大陸地區之法令、政治或經濟環境改變而受不同程度之影響。
九、 上列基金未經金管會核准或申報生效,不得於國內募集及銷售。基金資訊僅供既有投資人參考,本基金不接受任何新申購。
十、 上述資料只供參考用途,嘉實資訊自當盡力提供正確訊息,但如有錯漏或疏忽,本公司或關係企業與其任何董事或任何受僱人,恕不負任何法律責任。